Heterotopic transplantation as a model to study functional recovery of unloaded failing hearts

Journal of Thoracic and Cardiovascular Surgery

Volumn 124, Issue 6, 2002, Pages 1149-1156

  Tevaearai, Hendrik T ^a,b   Walton, G Brant ^a   Eckhart, Andrea D ^a   Keys, Janelle R ^a   Koch, Walter J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSISTED CIRCULATION; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HEART TRANSPLANTATION; HEART VENTRICLE REMODELING; HEART WORK; HETEROTOPIC TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0036896297     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2002.127315     Document Type: Article

References (28)

1. Mancini DM, Beniaminovitz A, Levin H, Catanese K, Flannery M, DiTullio M, et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation. 1998;98:2383-9.
2. Pietsch L, Laube H, Baumann G, Konertz W. Recovery from endstage ischemic cardiomyopathy during long-term LVAD support. Ann Thorac Surg. 1998;66:555-7.
3. Hetzer R, Muller J, Weng Y, Wallukat G, Spiegelsberger S, Loebe M. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. Ann Thorac Surg. 1999;68:742-9.
4. McCarthy PM, Nakatani S, Vargo R, Kottke-Marchant K, Harasaki H, James KB, et al. Structural and left ventricular histologic changes after implantable LVAD insertion. Ann Thorac Surg. 1995;59:609-13.
5. Zafeiridis A, Jeevanandam V, Houser SR, Margulies KB. Regression of cellular hypertrophy after left ventricular assist device support. Circulation. 1998;98:656-62.
6. Dipla K, Mattiello JA, Jeevanandam V, Houser SR, Margulies KB. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation. 1998;97:2316-22.
7. Bartling B, Milting H, Schumann H, Darmer D, Arusoglu L, Koerner MM, et al. Myocardial gene expression of regulators of myocyte apoptosis and myocyte calcium homeostasis during hemodynamic unloading by ventricular assist devices in patients with end-stage heart failure. Circulation. 1999;100 (Suppl):II-216-23.
8. A receptors but not endothelin-converting enzyme-1 in patients with end-stage heart failure. Circulation. 2000;102 (Suppl 3):III188-93.
9. Maurice JP, Shah AS, Kypson AP, Hata JA, White DC, Glower DD, et al. Molecular β-adrenergic signaling abnormalities in failing rabbit hearts after infarction. Am J Physiol. 1999;276(6 pt 2):H1853-60.
10. White DC, Hata JA, Shah AS, Glower DD, Lefkowitz RJ, Koch WJ. Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction. Proc Natl Acad Sci U S A. 2000;97:5428-33.
11. Shah AS, White DC, Tai O, Hata JA, Wilson KH, Pippen A, et al. Adenovirus-mediated genetic manipulation of the myocardial β-adrenergic signaling in transplanted hearts. J Thorac Cardiovasc Surg. 2000;120:581-8.
12. Depre C, Shipley GL, Chen W, Han Q, Doenst T, Moore ML, et al. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med. 1998;4:1269-75.
13. Lisy O, Redfield MM, Jovanovic S, Jougasaki M, Jovanovic A, Leskinen H, et al. Mechanical unloading versus neurohumoral stimulation on myocardial structure and endocrine function in vivo. Circulation. 2000;102:338-43.
14. max. J Heart Lung Transplant. 1999;18:524-31.
15. Hetzer R, Muller JH, Weng YG, Loebe M, Wallukat G. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage cardiomyopathy. J Thorac Cardiovasc Surg. 2000;120:843-53.
16. Rockman HA, Adamson RM, Dembitsky WP, Bonar JW, Jaski BE. Acute fulminant myocarditis: Long-term follow-up after circulatory support with left ventricular assist device. Am Heart J. 1991;121:922-6.
17. Hohlman WL, Bourge RC, Kirklin JK. Case report: Circulatory support for 70 days with resolution of acute heart failure. J Thorac Cardiovasc Surg. 1991;102:932-33.
18. Reiss N, el Banayosy A, Posival H, Morshuis M, Minami K, Korfer R. Management of acute fulminant myocarditis using circulatory support systems. Artif Organs. 1996;20:964-70.
19. Levin HR, Oz MC, Catanese KA, Rose EA, Burkhoff D. Transient normalization of systolic and diastolic function after support with a left ventricular assist device in a patient with dilated cardiomyopathy. J Heart Lung Transplant. 1996;15:840-2.
20. Martin J, Sarai K, Schindler M, van de Loo A, Yoshitake M, Beyersdorf F. MEDOS HIA-VAD biventricular assist device for bridge to recovery in fulminant myocarditis. Ann Thorac Surg. 1997;3:1145-6.
21. Frazier OH, Benedict CR, Radovancevic B, Bick RJ, Capek P, Springer WE, et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg. 1996;62:675-82.
22. Hetzer R, Muller JH, Weng Y, Meyer R, Dandel M. Bridging-to-recovery. Ann Thorac Surg 2001;71 Suppl:S109-13.
23. Heerdt PM, Holmes JW, Cai B, Barbone A, Madigan JD, Reiken S, et al. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation. 2000;102:2713-9.
24. Milting H, Bartling B, Schumann H, El Banayosy A, Wlost S, Ruter F, et al. Altered levels of mRNA of apoptosis-mediating genes after mid-term mechanical ventricular support in dilative cardiomyopathy: First results of the Halle Assist Induced Recovery Study (HAIR). Thorac Cardiovasc Surg. 1999;47:48-50.
25. Goldstein DJ, Moazami N, Seldomridge JA, Laio H, Ashton RC, Naka Y, et al. Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels. Ann Thorac Surg. 1997;63:971-4.
26. Akhter SA, Skaer CA, Kypson AP, McDonald PH, Peppel KC, Glower DD, et al. Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc Natl Acad Sci U S A. 1997;94:12100-5.
27. Mann DL, Willerson JT. Left ventricular assist devices and the failing heart: A bridge to recovery, a permanent device, or a bridge too far? Circulation. 1998;98:2367-9.
28. 2-adrenergic receptor to donor hearts enhances cardiac function. Gene Ther. 1999;6:1298-304.